• HPR92 Evolution of Technology Diffusion within Brazilian Universal Healthcare System (Sistema Único de Saúde - SUS) 2+ Years After Listing of Antiangiogenics Treatment for Age-Related Macular Edema (AMD)

    Jul 1, 2025, 00:00

  • EE303 The Time Value of Money driven by Early Disease-Modifying Interventions in Degenerative Disease

    Jul 1, 2025, 00:00

  • HSD17 Co-Design of a Discrete Choice Experiment for Revascularization Decisions in Complex Coronary Heart Disease: Importance of Patient Perspectives

    Jul 1, 2025, 00:00

  • EE310 Healthcare Resource Utilization by Severity of Disease Among Adult Patients With Asthma in the United States

    Jul 1, 2025, 00:00

  • MSR42 Three Different Methods to Estimate a Rare Disease (RD) Prevalence in a Country with a Limited Dataset: Which One Fits?

    Jul 1, 2025, 00:00

  • RWD95 Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US

    Jul 1, 2025, 00:00

  • RWD68 AUVI-Q vs. Other Epinephrine Auto-Injector Prescription Was Associated With Reduced Inpatient Hospitalizations for Anaphylaxis in a US Retrospective Commercial Claims Analysis

    Jul 1, 2025, 00:00

  • RWD164 ASCOT: A Case Study in Generating Timely and Meaningful Canadian Real-World Evidence To Support the Data Infrastructure Necessary for Innovative Patient Access

    Jul 1, 2025, 00:00

  • HSD26 Cancer Survivors and Opioid Use During Survivorship - A Scoping Review

    Jul 1, 2025, 00:00

  • RWD117 Concordance of ER and HER2 Status by Claims-Based Algorithm and Large Language Models (LLM) Abstracted Clinical Notes in Patients With Metastatic Breast Cancer (mBC)

    Jul 1, 2025, 00:00

  • RWD15 Characteristics of Patients With Minimal Residual Disease (MRD) Testing for Solid Tumors in a United States Population With Commercial or Medicare Advantage (MA) Insurance

    Jul 1, 2025, 00:00

  • HPR143 Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain

    Jul 1, 2025, 00:00

  • HSD99 Geographic Inequities in Bariatric Surgery Access in Southern Chile: The Case of the Chilean Bundled Payment PAD

    Jul 1, 2025, 00:00

  • EE442 Assessing the Relationship Between Pruritus and Work Productivity Among Individuals With PBC and Pruritus: Results From the ITCH-E Study

    Jul 1, 2025, 00:00

  • EE480 Surgical Stripping and Ligation Compared to Cyanoacrylate Vein Closure in the Mexican Public Healthcare Setting: Direct Costs and Incapacity Pay

    Jul 1, 2025, 00:00

  • PCR248 Adherence to Anti-Tubercular Medications in the United States: Insights from MarketScan Data (2016-2021)

    Jul 1, 2025, 00:00

  • EPH74 Characteristics of Patients Initiating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists (RAs) for Cardiometabolic Risk Reduction in a Medicare Population

    Jul 1, 2025, 00:00

  • RWD98 Association of Combined Opioid and Marijuana Use with Major Depressive Disorder among Adults with Chronic Conditions in the United States (US)

    Jul 1, 2025, 00:00

  • RWD123 Pharmacovigilance Studies Using a Representative Sample From the French National Health Insurance Database (ESND): A Targeted Literature Review

    Jul 1, 2025, 00:00

  • PCR201 Comparison of Rare Disease Patient and Caregiver Disease Burden in Terms of Economic, Social, and Interpersonal Impact and Impact on Quality Of Life: Results From an International Survey

    Jul 1, 2025, 00:00

  • The Argument-Based Approach to Validity Applied to Clinical Outcome Assessments: Some History and Notable Features

    Jul 1, 2025, 00:00

  • EE470 Cost-Effectiveness of Gabapentin, Pregabalin, and Duloxetine in the Treatment of Painful Diabetic Neuropathy: A Real-World Data-Based Net Benefit Regression Analysis

    Jul 1, 2025, 00:00

  • RWD102 Impact of Adverse Event Definitions on Real-World Detection of Oncology Immune-Related Adverse Events

    Jul 1, 2025, 00:00

  • PCR239 Improving Patient Engagement Outcomes: A Pilot Study to Investigate the Role of Empathy in Scientific Writing

    Jul 1, 2025, 00:00

  • HPR96 The Changing Impact of the Inflation Reduction Act on Payer Utilization Management- Insights from an Ongoing Quantitative Survey

    Jul 1, 2025, 00:00

  • PCR124 Factors Influencing the Quality of Life of Stroke Survivors: Results of an Online Survey in the US

    Jul 1, 2025, 00:00

  • EE499 Costs of Type 2 Diabetes Mellitus and Obesity in Colombian Caribbean Poor Population: A Top-Down Approach from a Cardiovascular Risk Cohort, 2020-2022

    Jul 1, 2025, 00:00

  • RWD71 Health Care Resource Utilization (HCRU), and Direct Medical Costs Among Patients With Locally Advanced or Metastatic HER2 Negative Gastric Cancer (GC) in the United States

    Jul 1, 2025, 00:00

  • EPH59 Application of Prevalent New-User Cohort Designs to a Claims Data Study of Incidence of Nutritional Deficiency in People With Diabetes Using GLP-1 Receptor Agonists

    Jul 1, 2025, 00:00

  • EPH147 Distribution, Inequalities and Associated Factors of Unmet Medical Needs Among Older Adults: Evidence From The National Health Service Survey

    Jul 1, 2025, 00:00

  • PCR5 Perspectives of Adult Patients and Caregivers on the Management and Challenges Associated With Neurofibromatosis Type 1 and Plexiform Neurofibroma: A Multinational, Qualitative Study

    Jul 1, 2025, 00:00

  • P33 Introduction of Distress Thermometer (DT) Screening in the US Community Oncology Setting: A Retrospective Study of Electronic Health Records (EHR) Integration

    Jul 1, 2025, 00:00

  • PT14 Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies

    Jul 1, 2025, 00:00

  • The Role of Mental Health in Healthcare Choices: A Discrete Choice Experiment Examining Preferences for Primary Care

    Jul 1, 2025, 00:00

  • RWD66 Utilizing Generative AI to Automate Model Selection and Network Meta-Analyses

    Jul 1, 2025, 00:00

  • PCR36 Enhancing Methods to Explore Meaningful Change in Patient Interviews: A Case Study in Spinocerebellar Ataxia (SCA)

    Jul 1, 2025, 00:00

  • EPH116 Informing Blood Donor Safety and Blood Supply Management in the United States: Factors Affecting Donor Time-To Return After Low Hemoglobin Deferral

    Jul 1, 2025, 00:00

  • MSR7 Transforming Regulatory Intelligence With AI Driven Methodologies in HEOR

    Jul 1, 2025, 00:00

  • HPR28 Interventions To Overcome the Challenges for Identifying Substandard, Spurious, Falsely Labeled, Falsified and Counterfeit Drugs (SSFFC). A Systematic Review

    Jul 1, 2025, 00:00

  • P42 Transportability of Treatment Effect Measures for Binary Outcomes in Population-Adjusted Indirect Comparisons

    Jul 1, 2025, 00:00

  • EE389 Cost-Effectiveness of Pembrolizumab as First-Line Treatment for Patients with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Unresectable or Metastatic Colorectal Cancer (CRC) from Public Payer Perspective ...

    Jul 1, 2025, 00:00

  • PCR15 Psychosocial Distress and Quality of Life Among Minority Men Diagnosed with Prostate Cancer: A Systematic Review

    Jul 1, 2025, 00:00

  • EE225 Cost Effectiveness Analysis of a Pharmacist-Led Clinical Decision Support System Powered by Machine Learning to Reduce Drug-Associated Acute Kidney Injury in the Adult Non-ICU Setting

    Jul 1, 2025, 00:00

  • HSD57 Highly Effective Use of a Medical Affairs Team with Medical Science Liaison-delivered Education: The SMART-MSL Study

    Jul 1, 2025, 00:00

  • EPH24 Sodium Glucose Co-Transporter 2 Inhibitor Exposure and the Risk of Congenital Malformations: Nationwide Birth Cohort Study

    Jul 1, 2025, 00:00

  • HTA36 Horizon Scanning for Paroxysmal Nocturnal Hemoglobinuria in Brazil: Insights on Past Trends and Future Prospects

    Jul 1, 2025, 00:00

  • PCR88 Patient Attitudes and Emotions Predict Health Outcomes: Evidence From the National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • PCR108 Assessing the Impact of Sociodemographic Factors on Patient Perceptions of Chronic Heart Failure Management

    Jul 1, 2025, 00:00

  • HSD62 Ten-Year Trends in Potentially Inappropriate Sedative-Hypnotics and Pain Medication Use among Medicare Part D Beneficiaries

    Jul 1, 2025, 00:00

  • MSR117 Estimation of Utilities for Patients with Metastatic Breast Cancer Using Vignette in Japan

    Jul 1, 2025, 00:00

  • RWD29 A Retrospective Cohort Study Evaluating the Association Between Fibrosis-4 Index and Major Adverse Cardiovascular Events in Patients with Metabolic Dysfunction-Associated Steatohepatitis

    Jul 1, 2025, 00:00

  • EE347 Updated 1-Year Fracture Incidence and Costs of Fragility Fractures in US Post-Fracture Patients Based on Commercial Claims Databases

    Jul 1, 2025, 00:00

  • MSR144 Physician-Augmented AI: Improving Machine Learning-Based Detection of NSCLC and Associated Clinical Indicators

    Jul 1, 2025, 00:00

  • MSR100 Can Gen-AI Assist in Translating Health Economic Data Across Formats? A Proof-of-Concept for an HEOR Translator Tool

    Jul 1, 2025, 00:00

  • HPR22 Comparing Hospital Prices Paid by Commercial Insurance Plans at 340B vs. Non-340B Hospitals: Implications for Employers and Patients

    Jul 1, 2025, 00:00

  • MSR62 Keeping With the Times: Emerging Methods for More Precise Survival Estimates to Inform Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • EE435 Integration of Environmental Considerations in Economic Evaluations: Significant Shift or Token Gesture? Insights From Severe Asthma Treatments

    Jul 1, 2025, 00:00

  • HSD92 Use of Novel Therapies for Multiple Myeloma in the United States: Important Differences in Patient Characteristics, Access to Care, and Real-World Treatment Challenges

    Jul 1, 2025, 00:00

  • PCR54 Preferences for Rapid Access Addiction Medicine Clinics Among Individuals with Problematic Alcohol Use A Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • MT6 Improving Cancer Recurrence Detection using ctDNA Measures in Colorectal, Breast, and Non-small Cell Lung Cancers

    Jul 1, 2025, 00:00

  • HSD16 Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey

    Jul 1, 2025, 00:00

  • EPH110 Trends in Vaccinations by Medicare Part D Beneficiaries

    Jul 1, 2025, 00:00

  • RWD154 Healthcare Resource Utilization (HCRU) and Costs of Poly(ADP-ribose) Polymerase Inhibitors (PARPi) as First-Line Maintenance (1LM) Treatment for Ovarian Cancer (OC)

    Jul 1, 2025, 00:00

  • EE515 Measuring the Spillover Effect of Cancer on Family Members' Health: A US-Based Empirical Analysis

    Jul 1, 2025, 00:00

  • HPR39 Health Insurance Use Among Young Pharmacists in Nigeria

    Jul 1, 2025, 00:00

  • MSR118 Cognitive Impairment Detection through Recurrent Neural Networks and Mobile Health Technologies

    Jul 1, 2025, 00:00

  • EPH40 Association between Exposure to GLP-1 Treatment and Pancreatitis Risk in Obesity Patients: A Retrospective Database Study

    Jul 1, 2025, 00:00

  • EE519 Economic Evaluation of Healthcare Point Solutions Versus Standard Care to Supplement Benefit Plans for Behavioral Health Adults Patients Using Real-World Synthetic Data: A Doubly Robust Causal Analysis

    Jul 1, 2025, 00:00

  • SA6 Changes in HbA1c and Body Weight in US Adults With Type 2 Diabetes and Chronic Kidney Disease Who Received Oral Semaglutide

    Jul 1, 2025, 00:00

  • EE227 Medical Costs in Patients with Pulmonary Arterial Hypertension (PAH) on Oral Triple Therapy including Selexipag in the United States (US): A retrospective Claims-Based Study

    Jul 1, 2025, 00:00

  • EPH32 Is there a GLP-1 Halo Effect? Potentially Better Overall Health Management Due to Starting GLP-1 for Weight Loss

    Jul 1, 2025, 00:00

  • EPH21 Socioeconomic Evaluation of Breast Cancer Attributable to Benzo[a]pyrene (BaP), Nitrogen Dioxide (NO2), and Polychlorinated Biphenyls 153 (PCB-153) Air Pollutants

    Jul 1, 2025, 00:00

  • EPH107 Patient-Provider Herpes Zoster Vaccination Discussion: Insights From Observed Primary Care Visits in the United States

    Jul 1, 2025, 00:00

  • MSR29 Reviewing Current Trends Regarding Use of Artificial Intelligence in Generating Real-World Evidence From Patient Medical Charts

    Jul 1, 2025, 00:00

  • EE277 Real-World Telehealth Utilization and Healthcare Costs in Commercially Insured Women With Breast Cancer: A Claims-Based Study

    Jul 1, 2025, 00:00

  • EE416 Molecular Profiling, Treatment (Tx) Patterns, and Healthcare Resource Utilization (HCRU) in United States Patients with Unresectable Locally Advanced/Metastatic Biliary Tract Cancer

    Jul 1, 2025, 00:00

  • HTA59 Revisiting Archetypes: New Archetypes for Strategic Global Value Evidence Planning

    Jul 1, 2025, 00:00

  • RWD91 A Retrospective Analysis of Real-World Data: Assessing and Predicting Cardiovascular Risk Associated with Calcium Channel Blockers in Patients with Hypertension

    Jul 1, 2025, 00:00

  • HTA63 Trends in Use of Cost-Minimization Analyses in CDA-AMC Reimbursement Submissions

    Jul 1, 2025, 00:00

  • CO24 Systematic Literature Reviews (SLRs) Of Clinical Outcomes And Patient-Reported Outcomes Of Recommended Treatments For Patients With Platinum-Resistant Ovarian Cancer (PROC)

    Jul 1, 2025, 00:00

  • HTA28 Health Equity and HTA: Is Equity Data Shaping Recommendations

    Jul 1, 2025, 00:00

  • PT1 Developing a Budget Impact R Shiney Application to Assess the Financial Implications of Implementing Organized Cancer Screening Programs in Countries with Limited Resources: Breast Cancer as an Example

    Jul 1, 2025, 00:00

  • HSD60 Impact of Pharmacist Managed Pulmonary Arterial Hypertension Program on TYVASO Adherence

    Jul 1, 2025, 00:00

  • PCR193 Treatment Experience and Other Health and Social Characteristics Among Patients With Cancer From a Large US Population-Based Survey

    Jul 1, 2025, 00:00

  • MT21 A New-to-Market Single-Use Ureteroscope: Urologist Performance Rating and Capability Assessment

    Jul 1, 2025, 00:00

  • MSR112 Can Multi-Cancer Early Detection Tests Reduce Cancer Mortality?

    Jul 1, 2025, 00:00

  • HSD112 Trends in Attainment of the Kidney Health Evaluation for Patients With Diabetes Measure Among Insured Individuals in the US, 2021-2024

    Jul 1, 2025, 00:00

  • EE441 Daily Intravenous Ketamine for Treatment-Resistant Depression: a Cost-Effectiveness Analysis Alongside the Clinical Trail

    Jul 1, 2025, 00:00

  • MT38 Does a Digital Health Program Influence One’s Choice of Traditional Health Care? Changes in Health Care Use and Episodic Cost Among a Group of Chronic MSK Patients in a Digital Conservative Musculoskeletal Care Program

    Jul 1, 2025, 00:00

  • PCR169 Impact of Primary Care Subsidies on Healthcare Utilization: Evidence From Singapore's Merdeka Generation Package

    Jul 1, 2025, 00:00

  • EPH64 Trends and Disparities in Weight Loss Activities Among Adults With Prediabetes and Obesity in the United States: 2009-2020

    Jul 1, 2025, 00:00

  • HPR25 Artificial Intelligence Software as a Medical Devi Regulatory Approvals and Post-Deployment Evaluation Frameworks in North America and Europe

    Jul 1, 2025, 00:00

  • HTA2 Role of Relative Dose Intensity in Health Economic Evaluations: A Review of National Institute for Health and Care Excellence Technology Appraisals of Treatments in Solid Tumors

    Jul 1, 2025, 00:00

  • P24 AI Tools for Literature Reviews: Are Current Guidelines Meeting the Needs of Researchers?

    Jul 1, 2025, 00:00

  • RWD78 Psychotropic Medication Treatment Patterns in Employee Dependents with Autism Spectrum Disorder

    Jul 1, 2025, 00:00

  • HPR140 The Importance of Medicare Advantage Plan Design and Impact on Health Equity

    Jul 1, 2025, 00:00

  • EE333 A Budget Impact Analysis of Introducing OPSYNVI for the Treatment of Adult Patients Diagnosed With Pulmonary Arterial Hypertension

    Jul 1, 2025, 00:00

  • PCR164 Development and Validation of the Symptom Assessment for Bronchiectasis (SABRE) for the FDA Qualification Program: A Novel Patient-Reported Outcome Instrument to Measure Symptoms of Non-Cystic Fibrosis Bronchiectasis

    Jul 1, 2025, 00:00

  • P30 Navigating Real-World Data (RWD) Complexities: Operational Assessment Strategy to Identify Fit-For-Purpose Data Sources for Real-World Evidence (RWE) Studies With Regulatory Purpose (OASIS)

    Jul 1, 2025, 00:00

  • RWD128 Device Longevity and Survival After Cardiac Resynchronization Therapy Pacemaker (CRT-P) Implantation in the Brazilian Public Health System (SUS): 12-Year Real-World Data Analysis

    Jul 1, 2025, 00:00

  • PCR218 Content Validation of the Most Bothersome Symptom - Essential Tremor Questionnaire (MBS-ET): A Cognitive Debriefing Study

    Jul 1, 2025, 00:00

  • RWD134 Follow Me, If You Can: How Tokenized Linkage Extends Patient Observations in Real-World Databases - the Komodo Research Dataset Example

    Jul 1, 2025, 00:00

  • EE260 A Real-World Analysis of Patient Cost Burden From COPD and Its Treatment Regimens

    Jul 1, 2025, 00:00

  • EE271 30-Day All-Cause Readmission Outcomes Among Kidney Transplant Recipients with vs. without Autosomal Dominant Polycystic Kidney Disease

    Jul 1, 2025, 00:00

  • Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States

    Jul 1, 2025, 00:00

  • EE504 Characterizing the Burden and Drivers of Healthcare Utilization and Spending for Epilepsy and Seizures in the U.S., 2016-2022

    Jul 1, 2025, 00:00

  • P35 Integrating Patient-Reported Outcomes in Clinical Care - Opportunities and Roadblocks From the Patient Perspective: A Scoping Review

    Jul 1, 2025, 00:00

  • MT40 Prospective, Comparative Study Between Fully-Automated and Semi-Automated Whole Blood Processing Systems in a Colombian Blood Bank Center

    Jul 1, 2025, 00:00

  • P63 Balancing Innovation and Affordability: Analyzing the Cost of Drugs for Rare Diseases in Canada

    Jul 1, 2025, 00:00

  • HSD50 Racial/Ethnic Disparities in Veterans' Healthcare Experiences Across VA and Non-VA Settings: An Analysis of the Medical Expenditure Panel Survey (2018-2019)

    Jul 1, 2025, 00:00

  • PT17 Challenges for PAIC in Rare Diseases: Results of a Systematic Literature Review

    Jul 1, 2025, 00:00

  • CO21 Real-World Evidence on Clinical Outcomes and Safety of Trastuzumab Biosimilar in Colombian Breast Cancer Patients

    Jul 1, 2025, 00:00

  • HSD111 Provider perspectives on the DREAMM-7 Trial Results and Belantamab Mafodotin (belamaf) in Combination with Bortezomib and Dexamethasone (B-Vd) as a Potential Treatment for Patients with Relapsed or Refractory Multiple Myeloma (R/R MM ...

    Jul 1, 2025, 00:00

  • HTA79 Annual Direct Medical Costs with Beta-Thalassemia in the Brazilian Public Healthcare System (SUS)

    Jul 1, 2025, 00:00

  • HTA84 Payer Perceptions on Creating a National Value assessment Body in the US

    Jul 1, 2025, 00:00

  • CO54 Systematic Literature Review and Network Meta-Analysis of Crovalimab Compared With Eculizumab, Ravulizumab and Best Supportive Care in Paroxysmal Nocturnal Hemoglobinuria

    Jul 1, 2025, 00:00

  • HPR98 Long-term Sustainability of National Essential Medicines Policy in Primary Care System in Rural Southwestern China from 2012-2017: Discrepancies by Facilities and Medicines

    Jul 1, 2025, 00:00

  • HTA11 A Standardized Framework for the Acceptance of Non-Randomized Evidence From Real-World Data in HTA: Insights From EU Guidelines and National Practices

    Jul 1, 2025, 00:00

  • HTA19 The Impact of Meeting Orphan Criteria on Reimbursement Decisions and ICERs in Scotland

    Jul 1, 2025, 00:00

  • EE483 Efficiency Benefits and Practice Value of Alcon's Digital Cataract Surgery Planning System

    Jul 1, 2025, 00:00

  • RWD133 Building on ‘Contemporary Practice and Considerations for Real-World Data (RWD) Source Identification and Feasibility Assessment’: Mapping Feasibility Criteria Across 46 Real-World Evidence (RWE) Guidelines

    Jul 1, 2025, 00:00

  • HPR110 Racial Disparities and the Impact of Access Restrictions to Apixaban in Part D

    Jul 1, 2025, 00:00

  • MSR80 Evaluation of Marginal Healthcare Expenditures and Health-related Quality of Life in Multiple Sclerosis with a Bayesian Quantile Machine Learning Approach

    Jul 1, 2025, 00:00

  • PT9 Application of ML-NMR to Time-to-Event Outcomes Using Parametric Models and Flexible Parametric (Spline) Models: A Case Study Using A Simulated Dataset

    Jul 1, 2025, 00:00

  • HPR51 Real-World Evidence in FDA Approvals for Labeling Extension of Drugs and Biologics

    Jul 1, 2025, 00:00

  • HTA13 Analysis of Reimbursement Outcomes for Oncology Therapies in Quebec, Canada

    Jul 1, 2025, 00:00

  • RWD156 Validation of Real-World Recurrence-Free Survival (rwRFS) and Distant Metastasis-Free Survival(rwDMFS) Endpoints in Early-Stage Melanoma

    Jul 1, 2025, 00:00

  • HSD29 National Assessment of Prostate and Colon Cancer Screening Using National Health Interview Survey (NHIS)

    Jul 1, 2025, 00:00

  • EE255 Economic Impact of Recurrence in High-Risk Early-Stage Estrogen-Receptor Positive (ER+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Breast Cancer (BC)

    Jul 1, 2025, 00:00

  • MT16 Economic Impact of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants

    Jul 1, 2025, 00:00

  • MSR119 Assessing the Impact of PD-L1 and BRAF Biomarkers on Long-Term Survivorship (LTS) Rates Among Treatment-Naive Advanced Melanoma Patients Receiving Immune Checkpoint Inhibitors (ICIs)

    Jul 1, 2025, 00:00

  • EPH144 Disease and Economic Burden of Dengue in Colombia, 2018-2022

    Jul 1, 2025, 00:00

  • CO27 Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in the Front-Line Maintenance Setting for Advanced Ovarian Cancer (OC): A Trial-Level Meta-Analysis

    Jul 1, 2025, 00:00

  • HSD72 Virtual Cancer Screening and Support Program: A Model for Improving Cancer Care Continuity Through Screening, Diagnosis, Treatment, and Survivorship

    Jul 1, 2025, 00:00

  • MSR61 Psychometric Validation of the Sunlight Exposure Diary and Erythropoietic Protoporphyria Impact Questionnaire (EPIQ) Using Data from the AURORA Clinical Study in Erythropoietic Protoporphyria (EPP)

    Jul 1, 2025, 00:00

  • EPH36 Global, Regional, and National Burdens of Type 1 and Type 2 Diabetes Mellitus in Adolescents from 1990 to 2021, with Forecasts to 2030: A Systematic Analysis of the Global Burden of Disease Study 2021

    Jul 1, 2025, 00:00

  • PCR153 The Vaccine Activation Measure (VAM™): Validation of a New Segmentation Tool for Understanding Vaccine Hesitance and Confidence

    Jul 1, 2025, 00:00

  • HTA23 Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs

    Jul 1, 2025, 00:00

  • EE335 Economic Burden of Hwabyeong in South Korea: An Analysis of Direct, Non-Medical, and Indirect Costs

    Jul 1, 2025, 00:00

  • HTA69 A Retrospective Analysis of the Italian Medicines Agency’s Evaluation of Real-World Evidence in Innovativeness Assessments

    Jul 1, 2025, 00:00

  • PT16 Assessing the Impact of Disparity on Hospital Outcomes: Review of 5 Diseases and their Unique Challenges

    Jul 1, 2025, 00:00

  • PCR180 Healthcare Burden Among Patients with Graves Disease: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • PCR227 Mapping the NEI-VFQ-25 to the EQ-5D-Y-3L and CHU-9D among High School Students with Myopia in China

    Jul 1, 2025, 00:00

  • PCR127 A Targeted Literature Review of Patient Perspectives of Placebo Use in Clinical Trials: How Can the Patient Voice Help Drug Developers in Trial Design, Recruitment, and Retention?

    Jul 1, 2025, 00:00

  • EE330 Correlation Between Price and Prevalence in Non-Oncology Orphan Products With Recent Trends (2015-2024)

    Jul 1, 2025, 00:00

  • RWD89 Leveraging Consumer-Grade Wearables in Clinical Trials: Insights From Digital Primary Endpoints

    Jul 1, 2025, 00:00

  • EE275 Economic Evaluation of Adjuvant Chemotherapy for Soft Tissue Sarcoma Using Linked NETSARC+ (French Registry) and SNDS (French National Health Data System) Real World Data: The Deepsarc Study

    Jul 1, 2025, 00:00

  • EE371 A European perspective on Health Resource Utilization (HRU) and Cost outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR251 Is There Value in Knowing? Perspectives of Cancer Screening Outcomes Among the US General Population

    Jul 1, 2025, 00:00

  • PCR84 Health Utility Values of Canadian Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer

    Jul 1, 2025, 00:00

  • HPR26 Are Existing Descriptions of Unmet Medical Need Fit for Purpose in the CMS Drug Negotiation Program Context?

    Jul 1, 2025, 00:00

  • EPH108 Prenatal Exposure to Antiseizure Medication and Risk of Adverse Obstetrical Outcomes: A Population-Based Study

    Jul 1, 2025, 00:00

  • EE474 Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Guatemala

    Jul 1, 2025, 00:00

  • HTA92 Diffusion and Launch Sequencing of Cell and Gene Therapies across the USA, Europe, Canada and Australia

    Jul 1, 2025, 00:00

  • HTA70 A Review of NICE UK Submissions for Antibody-Drug Conjugates in Oncology

    Jul 1, 2025, 00:00

  • MSR36 Methods for Handling Non-Proportional Hazards in Economic Modeling

    Jul 1, 2025, 00:00

  • EE438 Budget Impact Analysis of Lanadelumab Versus C1 Inhibitor for Hereditary Angioedema Long Term Prophylaxis: A Brazilian Private Sector Perspective

    Jul 1, 2025, 00:00

  • MSR114 Exploring the Impact of Data Availability on Time-Course Model-Based Network Meta-Analysis

    Jul 1, 2025, 00:00

  • EPH113 Characteristics of Patients Initiating Wegovy (Semaglutide) for Cardiovascular Risk Reduction in a Medicare Population

    Jul 1, 2025, 00:00

  • RWD153 A US Real-World Study of Weight Trajectory and Hypothalamic Damage Among Patients With Acquired Hypothalamic Obesity

    Jul 1, 2025, 00:00

  • HTA14 Empowering Healthcare Decision-Making: Leveraging Standardized Template for Enhanced Reliability and Efficiency in Budget Impact Analysis by Health Technology Assessment Agency

    Jul 1, 2025, 00:00

  • HTA60 Impact of a Digital Musculoskeletal Program on Healthcare Spending Among Participants with Chronic Musculoskeletal Pain and Comorbidities

    Jul 1, 2025, 00:00

  • PCR34 More than "financial toxicity": the Socioeconomic Impact of Cancer and Cancer Care on Patients and Their Relatives

    Jul 1, 2025, 00:00

  • HPR93 A Targeted Literature Review of Value-Based Agreements (VBAs) for Cell and Gene Therapies in the United States

    Jul 1, 2025, 00:00

  • RWD170 The Pen That Makes You Leaner: GLP-1 Prescription Trends for Weight Loss in the US

    Jul 1, 2025, 00:00

  • HPR116 Characterizing Social Determinants of Health in the Population Receiving Pneumococcal Vaccine in a National Pharmacy Chain in the United States

    Jul 1, 2025, 00:00

  • PCR190 Impact of Valbenazine on Improvements in Disability and Functional Impairment in Patients With Tardive Dyskinesia (TD): Sheehan Disability Scale (SDS) Results From a Phase 4 Randomized Withdrawal Study (NCT03891862)

    Jul 1, 2025, 00:00

  • PCR79 Assessing Quality-of-Life Outcomes in Ulcerative Colitis: A Review of Canadian HTA Submissions

    Jul 1, 2025, 00:00

  • EE391 Investing in Optimized HIV Prevention Among Young Men Who Have Sex With Men in Brazil: Insights From Fiscal Health Modeling

    Jul 1, 2025, 00:00

  • HPR45 The Cost of 340B to States

    Jul 1, 2025, 00:00

  • HPR127 Evolution of Technology Diffusion Within Brazilian Universal Healthcare System (Sistema Único De Saúde – SUS) 2+ Years After Listing of Antiangiogenics Treatment for Diabetic Macular Edema (DME)

    Jul 1, 2025, 00:00

  • HSD56 Bridging Racial Disparities in Aspirin Therapy for Preeclampsia Prevention Using Virtual Maternity Care

    Jul 1, 2025, 00:00

  • P49 A Health Technology Assessment Framework for Ethics Analysis in Drug Reimbursement Reviews at Canada's Drug Agency

    Jul 1, 2025, 00:00

  • PCR60 Exploring Patterns of App-Based Tracking of Real-World Symptom and Treatment Experiences in Patients with Sickle Cell Disease and Cystic Fibrosis

    Jul 1, 2025, 00:00

  • PCR85 The Socioeconomic Impact of Cancer and Cancer Care on Patients and Their Relatives: Assessing the Content Validity of Dedicated Patient-Reported Outcomes Measurement (PROM) Instruments

    Jul 1, 2025, 00:00

  • EE355 Healthcare Resource Utilization in the Management of Patients with Relapse/Refractory Mantle Cell Lymphoma in Canada

    Jul 1, 2025, 00:00

  • CO35 Predicted Effectiveness of First- and Second-Line Treatment Sequences in Advanced or Recurrent Endometrial Cancer

    Jul 1, 2025, 00:00

  • RWD130 Real-World Adverse Event Profile of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults

    Jul 1, 2025, 00:00

  • HPR153 The Reimbursement Status of Ustekinumab Across HTAs: A Global Perspective

    Jul 1, 2025, 00:00

  • HPR158 Is the Biologics Price Competition and Innovation Act Working as Intended?

    Jul 1, 2025, 00:00

  • HSD75 Evaluating the Association Between Medicare Star Ratings Part D Medication Adherence Measures and the Part C Plan All-Cause Readmission Outcome Measure

    Jul 1, 2025, 00:00

  • PCR222 Characterizing Improvements in Physical Functioning with PROMIS-PF and In-Trial Exit Interviews: A Mixed-Methods Analysis to Understand the Meaningful Changes Experienced by TGCT Patients on Vimseltinib in the MOTION Trial

    Jul 1, 2025, 00:00

  • EE451 Assessing the Operational Efficiency of a Vial Filling Robot in an Outpatient or a Community Pharmacy

    Jul 1, 2025, 00:00

  • EE254 Budget Impact Analysis of Revumenib for the Treatment of Relapsed or Refractory Acute Leukemias With a KMT2A Translocation in the United States

    Jul 1, 2025, 00:00

  • MSR14 Frailty Indices Using Claims Data - Examples from a Hospitalized Medicare Population

    Jul 1, 2025, 00:00

  • HPR48 Why It Is Still Important to Ensure the Price is Right: Updates to Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy

    Jul 1, 2025, 00:00

  • HPR125 Increasing Recognition Towards Inclusion of Patient Preferences in Healthcare Intervention Development and Access- Current Landscape and Way Forward

    Jul 1, 2025, 00:00

  • RWD100 Assessing the Proportion of Days Covered within 180 Days after First Medication Fills Among Bipolar Disorder Patients Using Real-World Data

    Jul 1, 2025, 00:00

  • PCR143 Psychometric Validation of the Modified Low Luminance Questionnaire in Patients With X-Linked Retinitis Pigmentosa

    Jul 1, 2025, 00:00

  • EPH99 Assessment of Real-World Adverse Events Associated with Ozanimod in Relapsing Remitting Multiple Sclerosis (RRMS)

    Jul 1, 2025, 00:00

  • EPH126 Identify the Adverse Drug Reactions Among Rheumatoid Arthritis Patients Being Administered Specific Classes of Disease-Modified Anti-Rheumatic Drugs (DMARDs)

    Jul 1, 2025, 00:00

  • EPH172 Exploring Pregnancy-Related Coding Practices in Administrative Claims Data: Insights for Health Outcomes Researchers

    Jul 1, 2025, 00:00

  • CO44 Comparative Risk of Major Adverse Cardiovascular Events among Patients who Initiate Treatment with Acute Migraine Agents

    Jul 1, 2025, 00:00

  • MSR2 Developing a Feature Selection Workflow for Variable-Rich Data: A Case Study Utilizing Claims Data to Build Classifiers for the Prediction of Opioid Use Disorder Among Persons Authorized to Purchase Medical Cannabis

    Jul 1, 2025, 00:00

  • RWD70 Barriers to Genetic Risk Factor Molecular Testing in CLL: An Analysis of Real-World Practice and Alignment with 2023 Guidelines in Germany

    Jul 1, 2025, 00:00

  • HPR5 Insight into Approvals, Marketing, and Pricing of New Medicines 2018 to 2022

    Jul 1, 2025, 00:00

  • P22 Assessment of Reasoning Agents for building Literature Search Strategies

    Jul 1, 2025, 00:00

  • EE476 Cost-Effectiveness of Pegfilgrastim Versus 5-day Filgrastim in Early Breast Cancer Patients Undergoing Neoadjuvant and Adjuvant Chemotherapy: A Trial-Based Economic Evaluation

    Jul 1, 2025, 00:00

  • P53 Alignment Between CDA Recommendations and pCPA Negotiation Outcomes: Exploring Factors Influencing Reimbursement Success

    Jul 1, 2025, 00:00

  • EPH122 First-Trimester Antiepileptic Drug Exposure and Adverse Pregnancy Outcomes: Insights from a Cohort Study in the US

    Jul 1, 2025, 00:00

  • Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses

    Jul 1, 2025, 00:00

  • RWD39 Examining Patterns in Breast Cancer Patient Characteristics and Treatment Throughout the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • EPH123 An Epidemiological Assessment of the Stroke Burden in Hungary Using Data From the Global Burden of Disease Study (1990–2021)

    Jul 1, 2025, 00:00

  • HPR138 2025 Review of Gene Therapy Access Landscape

    Jul 1, 2025, 00:00

  • CO67 The Potential Long-Term Comparative Effectiveness of Larotrectinib vs Repotrectinib for Treatment of NTRK Gene Fusion-Positive Cancers

    Jul 1, 2025, 00:00

  • MT3 Clinical and Economic Benefits of Branched Endovascular Stent Grafting for Intact Thoracoabdominal Aortic Aneurysm Repair: A Real-World Data Analysis

    Jul 1, 2025, 00:00

  • EE430 Medicare Cost Comparison of Transcarotid Artery Revascularization (TCAR) Versus Transfemoral Carotid Artery Stenting (TF-CAS)

    Jul 1, 2025, 00:00

  • PCR73 Discontinuation of Disease-Modifying Therapies in Older Adults with Multiple Sclerosis

    Jul 1, 2025, 00:00

  • MSR155 Assessing the Effectiveness of Large Language Models in Automating Systematic Literature Reviews: Findings from Recent Studies

    Jul 1, 2025, 00:00

  • EE243 Cost of Hypertension Cardiovascular and Renal Complications in Private Healthcare System in Brazil

    Jul 1, 2025, 00:00

  • EPH158 National Assessment of Depression Between Early vs Late Adolescents Using National Survey of Child Health Survey

    Jul 1, 2025, 00:00

  • HTA55 Effectiveness of Cell-Free Tumor DNA Tests in Early Lung Cancer Detection

    Jul 1, 2025, 00:00

  • RWD81 The Economic Burden of Illness for Patients with Idiopathic Pulmonary Fibrosis Utilizing Treatment Cohorts: A US Retrospective Claims Study

    Jul 1, 2025, 00:00

  • EE447 Integrating Dynamic Pricing Into Cost-Effectiveness Models: Implications for US-Based Drug Evaluations

    Jul 1, 2025, 00:00

  • HSD98 Bariatric Surgery Costs in Chile: Cost of a Comprehensive, Evidence-Based, and High-Quality of Care Program

    Jul 1, 2025, 00:00

  • PCR47 Social Listening: A Content Analysis of Social Media Discussions in Prader Willi Syndrome (PWS)

    Jul 1, 2025, 00:00

  • HPR61 US Food and Drug Administration Authorizations of Therapeutic Biologics and Biosimilars, 1980-2024

    Jul 1, 2025, 00:00

  • PT18 Prescribing Trends of Disease-Modifying Medications in Texas Medicaid Enrollees with Sickle Cell Disease

    Jul 1, 2025, 00:00

  • RWD1 Hemoglobin Levels and Social Determinants of Health as Risk-factors of End-Organ Damage in Sickle Cell Disease: A Retrospective Analysis

    Jul 1, 2025, 00:00

  • EE237 Real-World Treatment Patterns, Healthcare Costs and Resource Utilization in First-Line Treatment of Metastatic NSCLC in the US using MarketScan® data

    Jul 1, 2025, 00:00

  • EE250 Quantifying Spillover Impacts: Effect of Novel Therapies for IgA Nephropathy on Patients Awaiting Kidney Transplant

    Jul 1, 2025, 00:00

  • PCR81 Physician-Reported Satisfaction with, Challenges in, and Patient Adherence to, Immunosuppressive Treatment among Kidney Transplant Recipients: Results From a Real-World Survey

    Jul 1, 2025, 00:00

  • EE236 A Health Economic Evaluation of an Artificial Intelligence-Assisted Prescription Review System in a Real-World Setting in China

    Jul 1, 2025, 00:00

  • HSD67 Heterogeneity in Preferences for HIV Self-Testing Among Ugandan Men

    Jul 1, 2025, 00:00

  • HPR150 Review of Cell Therapy Access Landscape

    Jul 1, 2025, 00:00

  • HPR170 Private Insurance May Fail to Protect Against Healthcare Financial Hardship, Evidence from the 2018 and 2019 Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • EE305 Cost-Effectiveness of Maribavir for Post-Transplant Refractory (With or Without Resistance) Cytomegalovirus Infection in China

    Jul 1, 2025, 00:00

  • EE349 Costs of Type 1 Diabetes Acute and Chronic Complications in Brazil Private Healthcare System

    Jul 1, 2025, 00:00

  • HPR86 Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis

    Jul 1, 2025, 00:00

  • EE528 Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients with Metastatic Gastric/Gastroesophageal Junction Cancer in Commercially Insured Patients in the United States

    Jul 1, 2025, 00:00

  • EE354 Impact of Capacity and Resource Constraints on Wet Age-Related Macular Degeneration and Diabetic Macular Edema in the Brazilian Public Healthcare System: an Individual-Level Microsimulation Study

    Jul 1, 2025, 00:00

  • EE403 Estimating the Family Spillover Effects of Cardiovascular Diseases: Evidence from the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • EE453 Cost-Effectiveness Analyses of Repotrectinib in TKI-Naïve Patients with ROS1+ Advanced Non-Small Cell Lung Cancer

    Jul 1, 2025, 00:00

  • HPR134 Hepatitis C Elimination via Subscription-Based Payment Models: A Synthetic Control Study from Washington and Louisiana

    Jul 1, 2025, 00:00

  • PCR137 Patient and Physician Perspectives on Attributes of IO-Containing? Perioperative Treatments in Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer (NSCLC)

    Jul 1, 2025, 00:00

  • EE320 Impact of Diagnosis Delay on Healthcare Resource Utilization (HCRU) among Patients with Pulmonary Arterial Hypertension (PAH)

    Jul 1, 2025, 00:00

  • PCR87 Analysis of the Effect of Trofinetide Treatment on the Domain and Item-Level Responses of the Rett Syndrome Behavior Questionnaire Using Data From the LAVENDER Trial

    Jul 1, 2025, 00:00

  • PCR78 Approaches to Decreasing Emotional Burden during Qualitative Interviews to Improve Data Quality and Participant Engagement

    Jul 1, 2025, 00:00

  • EPH138 Dynamic Population Modelling Indicates a Flavored EVP Ban in the UK May Negatively Impact Population Health

    Jul 1, 2025, 00:00

  • EE364 Economic Evaluation of Single-Inhaler Extrafine Beclometasone Dipropionate/formoterol fumarate/glycopyrronium (Trimbow®) in Adult Patients with Uncontrolled Asthma in Mexico

    Jul 1, 2025, 00:00

  • RWD61 Assessing Antipsychotic Adherence in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real-World Data

    Jul 1, 2025, 00:00

  • EE297 Budget Analysis of the Implementation of Biosimilars in a Large Private Health Insurance Company in Southern Brazil

    Jul 1, 2025, 00:00

  • PCR115 Qualitative Assessment of the Idiopathic Hypersomnia Severity Scale: Suitability for Use As a Clinical Trial Endpoint as Demonstrated in NCT05156047

    Jul 1, 2025, 00:00

  • HPR21 Association between Socioeconomic Factors and Guideline-Directed Medical Therapy (GDMT) Utilization Among Medicare Beneficiaries with Heart Failure with Reduced Ejection Fraction (HFrEF)

    Jul 1, 2025, 00:00

  • EE339 Evaluating the Impact of Predictive Variables on Individual Biosimilar US Market Share

    Jul 1, 2025, 00:00

  • EPH119 Chronic Conditions Significantly Increase Risk of Severe RSV Outcomes in Medicaid Beneficiaries Aged 18-59 Years: A Claims Data Analysis

    Jul 1, 2025, 00:00

  • MSR75 Comparison of Generative AI and Manual Data Programming in a Lupus Health Productivity Loss Study

    Jul 1, 2025, 00:00

  • HSD36 Self-reported CAHPS Quality Measures by Medicare Beneficiary Social Vulnerability Index

    Jul 1, 2025, 00:00

  • EE374 Cost-Effectiveness Analysis of Dostarlimab Plus Chemotherapy As First-Line Treatment for Metastatic Non-Squamous Non-Small Cell Lung Cancer in Japan

    Jul 1, 2025, 00:00

  • PCR64 Enhancing Early-Phase Trial Outcomes: The Value of Patient-Reported Treatment Tolerability

    Jul 1, 2025, 00:00

  • CO79 Estimating the Effect of a Discontinued Amyotrophic Lateral Sclerosis Treatment on Time-to-Death Using Sequential Target Trial Emulation

    Jul 1, 2025, 00:00

  • EE421 Healthcare Cost Comparison Between 1L Ibrutinib and Acalabrutinib in Chronic Lymphocytic Leukemia Patients in the Veterans Affairs Population

    Jul 1, 2025, 00:00

  • EPH156 Evaluation of Chronic Conditions and Severe Outcomes in Adults Aged 18-59 Years With Medically Attended RSV Illness Using U.S. Commercial Claims Data

    Jul 1, 2025, 00:00

  • EPH135 Sex-Stratified Differences in Cardiac Interventions, Complications and Outcomes in the Netherlands Between 2018 and 2023

    Jul 1, 2025, 00:00

  • PCR186 JAV-RARAS: Evaluation of Adherence to Clinical Protocol and Therapeutic Guidelines (PCDT) for Mucopolysaccharidosis Type 2 (MPS2) at Codajás Polyclinic - An Analysis of the Value-Based Care Journey

    Jul 1, 2025, 00:00

  • MSR53 Development and Validation of an LLM-Based Study Selection Tool for Automating Systematic Literature Reviews: Achieving Time Efficiency and Maintaining Gold Standard Accuracy

    Jul 1, 2025, 00:00

  • HPR67 Canada’s Evolving Market for Biosimilars and What It Means for Payers

    Jul 1, 2025, 00:00

  • PCR151 Relationship Between Patient Engagement and Weight Management in a Pharmacist-led Clinic within a Managed Care Organization

    Jul 1, 2025, 00:00

  • PCR98 Enhancing Healthcare Quality through Patient-Centered Outcome Measures in Medicare's Merit-based Incentive Payment System

    Jul 1, 2025, 00:00

  • EE509 Considerations for Health Economic Modeling in Phenylketonuria (PKU): Insights From a Modified Delphi Panel

    Jul 1, 2025, 00:00

  • HTA29 Who Benefits From Technological Progress Among People With Type 1 Diabetes? Improvements in Glycemic Outcomes After CGM Adoption by Sociodemographic Characteristics

    Jul 1, 2025, 00:00

  • HPR56 Does the 340B Program Encourage and Reward Non-Profit Hospital Consolidation?

    Jul 1, 2025, 00:00

  • EE511 Descriptive Analysis Of Patients With Psoriasis (PSO) Using Biologics Vs. Non-biologics

    Jul 1, 2025, 00:00

  • MSR124 Impact of NICE Severity Modifiers on Willingness-to-Pay Thresholds

    Jul 1, 2025, 00:00

  • EPH26 Mortality due to Road Traffic Injuries in Colombia Before and After SARS-CoV-2 (2018-2022)

    Jul 1, 2025, 00:00

  • RWD165 Pioneering the Integration of Health-Equity Variables Into an Administrative Claims Database: A Step Forward in the Journey to Supporting Underserved Populations

    Jul 1, 2025, 00:00

  • EPH171 Gabapentinoid Use, Potential Misuse, and Associated Risk Factors among U.S. Adult Cancer Survivors: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • EPH129 Evaluation of Availability, Prices, and Affordability of Medicines for Hepatitis B and Hepatitis C Viruses at Community Pharmacies in a Senatorial District in North-Central Nigeria

    Jul 1, 2025, 00:00

  • EE267 Cost-Effectiveness of Dostarlimab in the Treatment of Newly Diagnosed Patients with Locally Advanced Rectal Cancer: Early Economic Modelling

    Jul 1, 2025, 00:00

  • EPH61 Algeria's Healthcare System in 2024: Progress Against Persisting Challenges

    Jul 1, 2025, 00:00

  • HPR99 Racial and Ethnic Disparities in Orphan Drug Utilization Among Medicare Beneficiaries

    Jul 1, 2025, 00:00

  • EE467 Acute Myocardial Infarction and Associated Healthcare Resource Utilization and Costs Among U.S. Patients With Extreme High Versus Low Lipoprotein (a)

    Jul 1, 2025, 00:00

  • EE216 Health and Economic Impact Analysis of Uncontrolled Hemophilia Patients in Colombia

    Jul 1, 2025, 00:00

  • P62 Characteristics of RWE used in Regulatory Decision-Making for Marketing Authorization Applications (MAAs)

    Jul 1, 2025, 00:00

  • PCR13 Content Validation of the Patient Attainment Scale-Essential Tremor (PAS-ET): A Novel Patient-Reported Outcome Measure Assessing Patient-Level Perceptions of the Importance, Current Function and Definitions of Meaningful Improvement i ...

    Jul 1, 2025, 00:00

  • MT18 Impact of Single-Patient Use Electrocardiogram Monitoring in the Cost of Care and Infection Prevention of CABG Surgery Patients in Canada

    Jul 1, 2025, 00:00

  • HSD37 Characteristics of Patients Enrolled in a Pharmacist Managed Rare Disease Program: Highlighting National Diversity and Representation

    Jul 1, 2025, 00:00

  • EPH9 A Retrospective Medical Expenditure Panel Survey Database Study Assessing Factors Associated with Health Status Among United States Adults with Asthma

    Jul 1, 2025, 00:00

  • CO8 Evaluating the Effects of the COVID-19 Pandemic on ICU Mortality and Sedation Charges in Mechanically Ventilated Patients

    Jul 1, 2025, 00:00

  • EE319 Economic Burden of Opioid-Induced Constipation Among Patients With or Without Cancer in the United States

    Jul 1, 2025, 00:00

  • PCR6 Impacts of Annual Wage on Insulin Adherence in Diabetes

    Jul 1, 2025, 00:00

  • EE370 The Costs Associated with Healthcare Resource Use and Work Productivity for Care Partners of Multiple Myeloma Patients in the United States and Europe

    Jul 1, 2025, 00:00

  • EE215 Pompe Disease in Sweden: A Real-World Evidence Study Investigating Healthcare Resource Utilisation and Costs

    Jul 1, 2025, 00:00

  • EE265 Key Clinical Drivers of the Long-Term Cost-Effectiveness of Semaglutide1mg for the Treatment of People With Type 2 Diabetes and Cronic Kidney Disease Based on the FLOW Clinical Trial

    Jul 1, 2025, 00:00

  • PCR245 Inclusion of Health-Related Quality of Life (HRQoL) and Other Patient-Reported Outcomes (PROs) in the United States Food and Drug Administration (FDA) Labels

    Jul 1, 2025, 00:00

  • RWD58 Concomitant Usage of Contra-Indicated Medications in Patients With Atrial Fibrillation: A Comparison of Real-World Data Sources in the United States

    Jul 1, 2025, 00:00

  • EE436 Real World Healthcare Resource Utilization (HRU) and Costs Associated With Mantle Cell Lymphoma (MCL) Therapies in the Frontline (1L) and Relapsed/Refractory (R/R) Setting

    Jul 1, 2025, 00:00

  • EPH10 Investigating the Pain Severity and Frequent Exercise Relationship in United States Adults Using the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • EE240 Economic Impact of Blister-Packaging on Medication Adherence in First-Line Multiple Myeloma Treatment

    Jul 1, 2025, 00:00

  • RWD157 K2GC: Real-world Treatments and Outcomes Amongst Patients With Resectable Gastric (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States (US)

    Jul 1, 2025, 00:00

  • PCR92 Renal Cell Carcinoma and Muscle Invasive Bladder Cancer Patients' Perception of Risk and Fear of Recurrence

    Jul 1, 2025, 00:00

  • MSR115 Prediction of Myasthenia Gravis (MG) Crisis Events by a Machine Learning (ML) Algorithm

    Jul 1, 2025, 00:00

  • P56 Biosimilar Optimization in Community Oncology Practices

    Jul 1, 2025, 00:00

  • EE481 Budget Impact Analysis of Volanesorsen as a Complement to the Diet in Adult Patients with Familial Chylomicronemia Syndrome (FCS) in Mexico

    Jul 1, 2025, 00:00

  • EPH162 Real-World Demographic and Clinical Characteristics of Patients With Atherosclerotic Cardiovascular Disease With or Without Chronic Kidney Disease or Systemic Inflammation in the United States

    Jul 1, 2025, 00:00

  • PT13 Clinician-Reported Outcomes—A Rare Opportunity for Orphan Labels?

    Jul 1, 2025, 00:00

  • MSR46 Evaluation of Machine Learning Assisted Title and Abstract Screening in 5 Clinical Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • PT29 Increased Incidence of Parkinson Disease Associated with Antiseizure Medication Use

    Jul 1, 2025, 00:00

  • OP8 Framework for Real-World Data Used in Regulatory Submissions

    Jul 1, 2025, 00:00

  • EE517 Willingness to Pay for a Quality Adjusted Life Year Across Different Time Horizons: Direct Elicitation in Quebec

    Jul 1, 2025, 00:00

  • EE434 An Economic Model to Estimate Costs of Adverse Events in Patients Treated With Lisocabtagene Maraleucel (liso-cel), Axicabtagene Ciloleucel (axi-cel), or Tisagenlecleucel (tisa-cel) for Relapsed/Refractory Follicular Lymphoma

    Jul 1, 2025, 00:00

  • EPH152 Trends in Cardiovascular and Cancer Mortality Among Texas Residents with Cancer between 2010 and 2019

    Jul 1, 2025, 00:00

  • MSR146 Identifying Redundant or Misfitting Items Using Item Response Theory: Type I and II Error Rates for Item Local Dependence and Misfit Detection in Clinical Outcome Assessments

    Jul 1, 2025, 00:00

  • CO18 Assessing the Comorbidity Burden of Ehlers-Danlos Syndromes (EDS): An Analysis Using US Real-World Data

    Jul 1, 2025, 00:00

  • HTA8 Trends in Indirect Treatment Comparison (ITC) Methods Used in Reimbursement Submissions in Canada and the US

    Jul 1, 2025, 00:00

  • PCR216 Predicting Future Type 1 Diabetes Onset Risk; A Machine Learning Approach

    Jul 1, 2025, 00:00

  • EE477 Healthcare Costs and Resource Utilization Associated With Knee Osteoarthritis and Obesity in the United States: A Retrospective Database Study

    Jul 1, 2025, 00:00

  • EPH89 What Are the Characteristics Associated With Frequent Physical Exercise Among Adults With Arthritis? Results of a National Survey in the United States

    Jul 1, 2025, 00:00

  • CO94 Impact of Individualized Neoantigen Therapies on Health, Productivity and Health System Capacity Outcomes in Resectable Melanoma in England

    Jul 1, 2025, 00:00

  • CO22 Real-World Effectiveness of Alcohol Use Disorder Treatment on Healthcare Utilization and Expenditure Among U.S. Adult Cancer Survivors: A Propensity-Score Matched Cohort Study

    Jul 1, 2025, 00:00

  • HPR73 Analysis of Out-of-Pocket Payments Associated with Female Infertility in Hungary Between 2015-2023

    Jul 1, 2025, 00:00

  • EPH136 Demographic Characteristics, Utilization Trends, and Access to GLP-1 Agonists Among Adults in a Nationally Representative Pharmacy Database

    Jul 1, 2025, 00:00

  • RWD106 Cardiovascular Morbidity and Mortality Among ATTR-CM Patients Treated with Tafamidis in the US

    Jul 1, 2025, 00:00

  • HPR36 Estimated Impact of the Inflation Reduction Act on Out-of-Pocket Spend Among Medicare Part D Beneficiaries with Cancer

    Jul 1, 2025, 00:00

  • P50 Quantifying Treatment Value Using Alternative Health Benefit Metrics: A Case Study of Adjuvant Osimertinib for Elderly Patients with EGFR mutated NSCLC Following Resection

    Jul 1, 2025, 00:00

  • EE202 Economic Evaluations of Imaging Guidance for Percutaneous Coronary Interventions: A Scoping Review

    Jul 1, 2025, 00:00

  • EE229 Cost-Effectiveness Analysis of First-Line Tremelimumab Plus Durvalumab Versus Sorafenib in Unresectable Hepatocellular Carcinoma

    Jul 1, 2025, 00:00

  • CO45 Systematic Review of Secondary Primary Malignancies (SPMs) in Patients Treated with Chimeric Antigen Receptor T-cell (CAR-T) Therapies

    Jul 1, 2025, 00:00

  • PCR61 Exploring the Health and Well-being of Pediatric Caregivers within Chinese Cultural Contexts: A Systematic Review of Qualitative Studies from Chinese Databases

    Jul 1, 2025, 00:00

  • PCR129 Utility Values From Individuals With Knee Osteoarthritis in the UK

    Jul 1, 2025, 00:00

  • HTA44 Reimbursement Outcomes for EMA Conditionally Authorized Orphan Drugs (2022-2023): Implications for Joint Clinical Assessment Requirements

    Jul 1, 2025, 00:00

  • PT10 Patient-Reported Outcome Endpoint Emulation in Heart Failure External Control Arm Study (EMULATE-HF PRO-ECA Study)

    Jul 1, 2025, 00:00

  • HTA42 Better Off Dead: Mitigating For Situations Where Improving Survival Isn't Cost-Effective

    Jul 1, 2025, 00:00

  • OP5 Analysis of the Human Development Index by Innovation In Health, Through the Incorporation of New Technologies In Oncology: Preliminary Data in LMIC/LATAM/Brazil

    Jul 1, 2025, 00:00

  • P57 Frequency of ICER Miscalculation and Misinterpretation in Published Cost-Effectiveness Analysis Comparing More Than Two Alternatives

    Jul 1, 2025, 00:00

  • EE405 Trial-Based Economic Evaluation of 'Partner in Balance,' a Blended Self-management Program for Early-Stage Dementia Caregivers in the Netherlands: The Health-Economic Analysis Plan and Baseline Results

    Jul 1, 2025, 00:00

  • PCR194 Qualitative Evaluation of a Tool for Collecting Stated and Revealed Patient Preferences in the Context of Atypical Antipsychotics for the Treatment of Depression or Bipolar Disorder in Adults

    Jul 1, 2025, 00:00

  • EPH23 Epidemiology and Disease Burden of Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, and Systemic Inflammation in Northern China: A Retrospective Study of Tianjin Regional Electronic Health Records

    Jul 1, 2025, 00:00

  • RWD101 Epidemiology, Demography and Comorbidities of Patients With Osteoporosis at Very High Risk of Fracture in China

    Jul 1, 2025, 00:00

  • EE392 State of Evidence on Cost-Effectiveness Analysis of Health Technologies in Colombia: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • RWD172 Implementation of New Real-World Data Quality Frameworks and Initiatives to Address Challenges in Oncology Electronic Health Record (EHR)-Derived Databases for Research

    Jul 1, 2025, 00:00

  • HPR43 Unlocking the Potential of OBRSAs in the US: Insights on Challenges, Policy Changes, and Pathways Forward

    Jul 1, 2025, 00:00

  • PCR23 A Growing Trend: The Expanding Use of Patient-reported Outcome Measures (PROMs) in Clinical Trials (2008-2023)

    Jul 1, 2025, 00:00

  • CO91 Real-World Events Often Associated with Relapse (EOAR) Rates Among Patients with Multiple Sclerosis on Natalizumab Using Claims Data from the PearlDiver Mariner Database

    Jul 1, 2025, 00:00

  • HPR70 Revisiting Conflicts in Population-Adjusted Indirect Comparisons: A Duality Perspective

    Jul 1, 2025, 00:00

  • PCR156 Frequency and Severity of COVID-19 Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2: Early 2024-2025 Respiratory Season Results of a Nationwide Study

    Jul 1, 2025, 00:00

  • HSD110 Real-World Subcutaneous Monoclonal Antibody Use Trends for Oncology in the US

    Jul 1, 2025, 00:00

  • RWD22 Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic HR+ HER2- Breast Cancer

    Jul 1, 2025, 00:00

  • EE288 Economic Burden and Healthcare Resource Utilization (HCRU) Associated with High-Risk Papillary Stage Ta T1 (PAPTa1) Non-Muscle Invasive Bladder Cancer (NMIBC) Patients, 2008-2019

    Jul 1, 2025, 00:00

  • HSD20 An Analysis of Hospitalization Metrics After Intravenous (IV) Ferric Derisomaltose (FDI) versus Usual Care (UC) in Patients with Iron Deficiency Anemia (IDA) and Heart Failure (HF) Based on IRONMAN

    Jul 1, 2025, 00:00

  • EPH62 Estimation of Treatment Eligible Patients With Transthyretin Cardiac Amyloidosis Within a Health Plan

    Jul 1, 2025, 00:00

  • PCR166 Tremor Symptoms and Associated Activities of Daily Living Impacts in Essential Tremor: A Qualitative Concept Elicitation and Mapping Study

    Jul 1, 2025, 00:00

  • RWD40 Real World Treatment Patterns for Castration-Sensitive Prostate Cancer Between 2012 and 2024 : A Systematic Review

    Jul 1, 2025, 00:00

  • MSR88 Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research

    Jul 1, 2025, 00:00

  • RWD13 Real-World Use of Biologics in the Treatment of Psoriasis and Ankylosing Spondylitis in China: The Case of Secukinumab

    Jul 1, 2025, 00:00

  • EPH52 Protocol for a Real-World Retrospective Study on Chronic Obstructive Pulmonary Disease Outcomes Among Individuals Switching to Heated Tobacco Products Compared to Continued and Former Cigarette Smokers in Japan

    Jul 1, 2025, 00:00

  • PCR184 Measuring and Reporting Health-Related Quality of Life (HRQoL) in Locally Advanced/Metastatic Urothelial Cancer (La/mUC) Research: Capturing Outcomes That Really Matter to Patients

    Jul 1, 2025, 00:00

  • RWD169 Real-World Utilization and Predictors of Neurohormonal Inhibitors Use in Young and Middle-Aged Breast Cancer Patients, Initiating Anthracycline-Based Treatments

    Jul 1, 2025, 00:00

  • HPR90 Value Communications With US Payers: The Value of Storytelling

    Jul 1, 2025, 00:00

  • EPH124 EHR Trends in First-Time ADHD Diagnoses and Amphetamine Prescriptions Across Age Groups (2021-2024)

    Jul 1, 2025, 00:00

  • HPR142 The Evolution of Value-Based Agreements in US Healthcare: Barriers, Opportunities, and Future Prospects

    Jul 1, 2025, 00:00

  • MSR82 Effectiveness of Activity Criteria in Stabilizing Patient Cohorts in Open Claims Data for Healthcare Outcomes Research

    Jul 1, 2025, 00:00

  • MT28 Harnessing Digital Measures of Physical Function in Neurological Conditions: Findings From a Targeted Literature Review

    Jul 1, 2025, 00:00

  • MSR10 Real-time Predictions of Maternity Episode Expenses Using Machine Learning

    Jul 1, 2025, 00:00

  • RWD111 Unmet Need in CIDP Patients Treated With Immunoglobin: Results of a Multinational Real-World Survey

    Jul 1, 2025, 00:00

  • CO23 Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Naïve Patients with T2D

    Jul 1, 2025, 00:00

  • MSR116 Trends in Current Smoker Profiles Among US Adults From 2019-2024: An Unsupervised Clustering Analysis

    Jul 1, 2025, 00:00

  • HPR82 Real-World Evidence in FDA and EMA Regulatory Reviews: Insights on Its Role in Submission Packages and Approvals

    Jul 1, 2025, 00:00

  • MSR90 From Bias to Confiden Exploring Quantitative Bias Analysis’ (QBA’s) Role in Matching Adjusted Indirect Treatment Comparison

    Jul 1, 2025, 00:00

  • Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States

    Jul 1, 2025, 00:00

  • PCR16 Integrating Patient-Reported Outcomes in Clinical Care: Opportunities and Roadblocks from the Clinician Perspective: A Scoping Review

    Jul 1, 2025, 00:00

  • RWD7 Youth Mental Health Crisis: Economic Impacts and HEOR Opportunities

    Jul 1, 2025, 00:00

  • P52 A Policy Framework for Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment (HTA)

    Jul 1, 2025, 00:00

  • RWD150 The HER2-TRENDS StudyHR Positive - HER2 Negative Metastatic Breast Cancer (mBC) Treatment Patterns and Clinical Outcomes in Canada

    Jul 1, 2025, 00:00

  • EPH168 Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses

    Jul 1, 2025, 00:00

  • HSD25 Efficacy of Improvisational Communication Training for Health Workers in Emergency Care Unit in Hungary: Quazy Experimental Study

    Jul 1, 2025, 00:00

  • CO37 A Clinical Prediction Model of Asymptomatic Left Ventricular Dysfunction in Survivors of Childhood Cancer in Ontario, Canada

    Jul 1, 2025, 00:00

  • PCR147 Comparison of Rare Disease Patient and Caregiver Perceptions Regarding Access to Disease Information and Interactions with their Healthcare Providers: Results from an International Survey

    Jul 1, 2025, 00:00

  • CO61 Suicidal Ideation in Patients Treated With Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis

    Jul 1, 2025, 00:00

  • Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report

    Jul 1, 2025, 00:00

  • CO11 Comparative Analysis of Robotic-Assisted, Laparoscopic, and Open Radical Nephrectomy: Trends, Costs, and Clinical Outcomes

    Jul 1, 2025, 00:00

  • HSD54 Receipt of Guideline Concordant Treatment Among Older Adults Newly Diagnosed With Stage III - IV Melanoma Using SEER-Medicare Linked Data

    Jul 1, 2025, 00:00

  • PCR200 Exploring the Impact of Exercise Variability of Mental Health: Results From the 2024 US National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • HTA64 Validation of Artificial Intelligence (AI) Tool to Identify PICO Questions for EU Joint Clinical Assessment (JCA)

    Jul 1, 2025, 00:00

  • EE224 Evaluating Attributes of Non-Oncology Orphan Approvals From 2015-2024

    Jul 1, 2025, 00:00

  • EE341 Economic Burden of Prader-Willi Syndrome Among Pediatric Patients in the United States

    Jul 1, 2025, 00:00

  • HPR6 Market Access Challenges for Innovative Medications in Women's Health in Canada: Overview of the Past 20 Years

    Jul 1, 2025, 00:00

  • EE231 The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in the UK

    Jul 1, 2025, 00:00

  • PCR94 Use of Diaries to Capture Patient-Reported Outcomes in FDA New Drug Approvals (2019-2023)

    Jul 1, 2025, 00:00

  • EE463 A Longitudinal Year-by-Year Cost Analysis for Patients Diagnosed with Polycythemia Vera

    Jul 1, 2025, 00:00

  • HTA27 How Have Canada's Drug Agency Guidelines Impacted Choice of Model Structure and Use of Partitioned Survival Models in Oncology Submissions?

    Jul 1, 2025, 00:00

  • PCR149 Patient Optimism and the Trade-Off Between Kidney Quality and Waiting Time

    Jul 1, 2025, 00:00

  • PCR107 Differential Item Functioning With the National Eye Institute Visual Function Questionnaire-25 in Patients With Vitreomacular Traction

    Jul 1, 2025, 00:00

  • MSR17 A Comparative Assessment of LLM Agreement for Clinical Data Extraction Tasks

    Jul 1, 2025, 00:00

  • PCR18 Comparative Analysis of Smartphone Application and Web-based Electronic Clinical Outcome Assessment (eCOA) Modalities

    Jul 1, 2025, 00:00

  • EPH31 Prevalence of Hypertension Over (Calendar) Time Among People With Narcolepsy Treated With Oxybate

    Jul 1, 2025, 00:00

  • RWD34 Advancing the Development of Real-World Data for Cancer Care in China: Challenges and Opportunities

    Jul 1, 2025, 00:00

  • CO5 Patient Journey Prior to the Diagnosis of Niemann-Pick Disease Type C

    Jul 1, 2025, 00:00

  • EE526 Impact of Recurrence Modelling on Cost-Effectiveness of New Treatments for Early Cancers

    Jul 1, 2025, 00:00

  • HPR154 The Impact of the Inflation Reduction Act on Rare Diseases and Orphan Drugs

    Jul 1, 2025, 00:00

  • CO55 A Retrospective Real-World Data Analysis of Pregnancy Outcomes Among Women with a History of Hysteroscopic Intrauterine Adhesiolysis (HA), Other Intrauterine Surgery (IUs), or no Prior IUs

    Jul 1, 2025, 00:00

  • MT27 Impact of Single-Patient use Electrocardiogram Monitoring in the Cost of Care and Infection Prevention of CABG Surgery Patients in the USA

    Jul 1, 2025, 00:00

  • EE263 Population-Level Impact of Emicizumab for Hemophilia A Patients in Six Latin American (LATAM) Countries: A 25-Year Model

    Jul 1, 2025, 00:00

  • RWD18 Treatment Patterns and Healthcare Resource Utilization in Patients Diagnosed With CRSwNP in HMO From Colombia: A Real Word Evidence Study

    Jul 1, 2025, 00:00

  • HSD2 Cognitive Impairment at Initial Diagnosis of Alzheimer’s Disease: Patient Characteristics and Treatments in the Real-World Setting

    Jul 1, 2025, 00:00

  • EE309 Examination of the Two-Year US Commercial Payer Budget Impact (BI) of the Leva Pelvic Health System, a Prescription Medical Device That Provides Supervised Pelvic Floor Muscle Training (PFMT) As First-Line Treatment for Female Urinary ...

    Jul 1, 2025, 00:00

  • PCR109 Is It Time to Rethink Proxy-Reporting? Feasibility and Psychometric Considerations for Creating ObsROs That Adhere to Patient-Focused Drug Development (PFDD) Fit-for-Purpose Guidance

    Jul 1, 2025, 00:00

  • EE322 Cost and Clinical Characteristics of Acute Pancreatitis Hospitalizations Related and Unrelated to Hypertriglyceridemia

    Jul 1, 2025, 00:00

  • RWD24 Optimizing EHR Data Completeness: A Conceptual Framework for Bringing Real-World Data into Clinical Research through Relevant Completeness

    Jul 1, 2025, 00:00

  • RWD44 Clinical Validation of Large Language Model for Automated Extraction of Genetic Testing Data

    Jul 1, 2025, 00:00
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »